These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9816182

  • 1. Expression of bcl-2 and the progression of human and rodent prostatic cancers.
    Furuya Y, Krajewski S, Epstein JI, Reed JC, Isaacs JT.
    Clin Cancer Res; 1996 Feb; 2(2):389-98. PubMed ID: 9816182
    [Abstract] [Full Text] [Related]

  • 2. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ.
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [Abstract] [Full Text] [Related]

  • 3. Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer.
    Rothermund CA, Kondrikov D, Lin MF, Vishwanatha JK.
    Prostate Cancer Prostatic Dis; 2002 Mar; 5(3):236-45. PubMed ID: 12496988
    [Abstract] [Full Text] [Related]

  • 4. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ, van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM, Schalken JA.
    Cancer Res; 1992 May 15; 52(10):2916-22. PubMed ID: 1581909
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y, Chatterjee SJ, Brands FH, Shi SR, Pootrakul L, Taylor CR, Datar R, Cote RJ.
    BJU Int; 2006 Jan 15; 97(1):170-8. PubMed ID: 16336351
    [Abstract] [Full Text] [Related]

  • 13. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.
    Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
    Angelucci C, Iacopino F, Lama G, Capucci S, Zelano G, Boca M, Pistilli A, Sica G.
    Anticancer Res; 2004 Mar 01; 24(5A):2729-38. PubMed ID: 15517879
    [Abstract] [Full Text] [Related]

  • 15. Programmed death of nonproliferating androgen-independent prostatic cancer cells.
    Martikainen P, Kyprianou N, Tucker RW, Isaacs JT.
    Cancer Res; 1991 Sep 01; 51(17):4693-700. PubMed ID: 1873814
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.
    Gupta S, Afaq F, Mukhtar H.
    Oncogene; 2002 May 23; 21(23):3727-38. PubMed ID: 12032841
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.
    Cancer J; 2000 May 23; 6(4):220-33. PubMed ID: 11038142
    [Abstract] [Full Text] [Related]

  • 20. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N, Korkmaz CG, Saatcioglu F.
    Oncogene; 2002 Feb 07; 21(7):1017-27. PubMed ID: 11850819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.